Neovision Capital
Shanghai, Shanghaineovisioncap.com
Overview
Neovision Capital is an investment fund that specializes in the venture capital investments in growth companies. The firm prefers to invest in the healthcare, information technology, TMT and consumer products and services sectors. The company leverages its team's extensive operational experience in China, along with international resources, to provide strategic support to its portfolio companies. This includes expertise in areas such as branding, marketing, channel development, overseas expansion, human resources, and finance. Neovision Capital also maintains a presence in Nanjing.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BrioHealth Solutions | Jul 2025 | Series E | Lead |
| BrioHealth Solutions | Jul 2025 | Series E | Lead |
| Sino-Biocan (Shanghai) Biotech Ltd | Mar 2024 | Series B | Co-investor |
| Qingdao Single-Cell Biotechnology Co., Ltd. | Jul 2022 | Pre Seed | Lead |
| ALVA Systems | Dec 2021 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.